At a glance
ClinicalIndex Comparison RecordPhase 1Completed· 35 enrolled
Drug / intervention
Probenecid or placebo single administrationdrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Probenecid as Pharmacotherapy for Alcohol Use Disorder
In Brief
A Phase 1 clinical trial evaluating Probenecid or placebo single administration for Alcohol Use Disorder. Completed, enrolled 35 participants across 1 site.
Detailed Summary
The design is a randomized, within-subject, crossover, double-blind, placebo-controlled human alcohol laboratory study with one oral dose of 2g probenecid or placebo administered in two laboratory sessions.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAlcohol Use Disorder
CountriesUnited States
Collaborators--
Timeline
Phase 1CompletedFinished
2020202120222023202420252026
First PostedJan 2020
Enrollment StartDec 2020
Primary CompletionMay 2023
Study CompletionMay 2023
TodayJul 2026
First PostedJan 6, 2020
Enrollment StartDec 2, 2020
Primary CompletionMay 16, 2023
Study CompletionMay 20, 2023
TodayJul 2, 2026
Enrollment to primary: 2.5 yearsPosted 6.5 years ago
Interventions
Probenecid or placebo single administrationdrug
study drug administration with alcohol in the laboratory